Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: A preliminary report of the national cancer institute organ dysfunction working group

被引：36

作者：

Doroshow, JH

Synold, TW

Gandara, D

Mani, S

Remick, SC

Mulkerin, D

Hamilton, A

Sharma, S

Ramanathan, RK

Lenz, HJ

Graham, M

Longmate, J

Takimoto, CH

Ivy, P

机构：

[1] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA

[2] Univ Calif Davis, Ctr Canc, Sacramento, CA USA

[3] Albert Einstein Coll Med, Bronx, NY 10467 USA

[4] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA

[5] Univ Wisconsin, Ctr Comprehens Canc, Madison, WI USA

[6] NYU, Kaplan Canc Ctr, New York, NY 10016 USA

[7] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[8] Univ Pittsburgh, Ctr Comprehens Canc, Pittsburgh, PA USA

[9] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[10] Sanofi Synthelabo Inc, Dept Clin Pharmacokinet & Drug Met, Malvern, PA USA

[11] Univ Texas, Hlth Sci Ctr, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX USA

[12] NCI, Invest Drug Branch, Canc Therapy Evaluat Program, Div Canc Treatment & Diag, Bethesda, MD USA

来源：

SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 04期

关键词：

D O I：

10.1016/S0093-7754(03)00400-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：14 / 19

页数：6

共 16 条

[1]

An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma [J].

Chau, I ;

Webb, A ;

Cunningham, D ;

Hill, M ;

Rao, S ;

Ageli, S ;

Norman, A ;

Gill, K ;

Howard, A ;

Catovsky, D .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (04) :786-792

[2]

Chollet P, 1996, ANN ONCOL, V7, P1065

[3]

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer [J].

deGramont, A ;

Vignoud, J ;

Tournigand, C ;

Louvet, C ;

Andre, T ;

Varette, C ;

Raymond, E ;

Moreau, S ;

LeBail, N ;

Krulik, M .

EUROPEAN JOURNAL OF CANCER, 1997, 33 (02) :214-219

[4]

HIGH-DOSE CISPLATIN WITH DIETHYLDITHIOCARBAMATE (DDTC) RESCUE THERAPY - PRELIMINARY PHARMACOLOGIC OBSERVATIONS [J].

DEGREGORIO, MW ;

GANDARA, DR ;

HOLLERAN, WM ;

PEREZ, EA ;

KING, CC ;

WOLD, HG ;

MONTINE, TJ ;

BORCH, RF .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (05) :276-278

[5]

DOROSHOW J, 1982, P AN M AM SOC CLIN, V1, P11

[6]

Fink D, 1996, CANCER RES, V56, P4881

[7]

Graham MA, 2000, CLIN CANCER RES, V6, P1205

[8]

Combination of oxaliplatin and irinotecan on human colon cancer cell lines:: activity in vitro and in vivo [J].

Guichard, S ;

Arnould, S ;

Hennebelle, I ;

Bugat, R ;

Canal, P .

ANTI-CANCER DRUGS, 2001, 12 (09) :741-751

[9]

MAMENTA EL, 1994, CANCER RES, V54, P3500

[10]

Oxaliplatin: A review of evolving concepts [J].

Mani, S ;

Graham, MA ;

Bregman, DB ;

Ivy, P ;

Chaney, SG .

CANCER INVESTIGATION, 2002, 20 (02) :246-263

← 1 2 →